pharma exec for maker of $150,000 cancer drug tells investors its pricing is very responsible /

Published at 2015-12-30 15:39:54

Home / Categories / Unofficial sources / pharma exec for maker of $150,000 cancer drug tells investors its pricing is very responsible

A top official at Johnson & Johnson dismissed questions approximately drug price reform debate, saying that the company is “responsible” in pricing its drugs.
The post Pharma Exec for Maker of $150000 Cancer Drug Tells Investors Its Pricing Is Very Responsible” appeared first on The Intercept.

Source: firstlook.org